Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
bristol-myers squibb
3
×
clinical trials
gene therapy
3
×
life sciences
national
national blog main
national top stories
novartis
3
×
zolgensma
abbvie
avexis
biogen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
crispr
deals
detroit blog main
detroit top stories
eli lilly
glaxosmithkline
indiana blog main
indiana top stories
johnson & johnson
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
satsuma pharmaceuticals
seattle blog main
seattle top stories
texas blog main
What
bio
news
roundup
access
advanced
approval
august
biogen’s
biopharmaceutical
biotech
busy
capacity
car
cell
companies
consolidation
convo
crispr
days
decisions
devices
drug
drugs
earlier
failures
falcon
fda
focus
gene
legacy
littered
milestones
nash
new
nods
opioid
past
patient
powered
price
Language
unset
Current search:
novartis
×
" gene therapy "
×
" bristol-myers squibb "
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More